The Numbers Don't Lie: Pfizer Earnings Preview

The video discusses the cancellation of the $160 billion merger between Allergan and Pfizer due to new US Treasury rules on tax inversions. It highlights Pfizer's financial performance, with its global established products unit generating significant sales in 2015. The video also covers Pfizer's business strategy, including the potential spinoff of its established products unit and the impact of acquiring Hospira. Key drivers of Pfizer's pharmaceutical sales, such as vaccines, are examined, along with an analysis of its drug pipeline and recent healthcare market trends.

What are the main drivers of Pfizer's business according to the text?

What was the reaction of analysts towards Pfizer's drug pipeline?